Nektar Therapeutics & Philip Kim
1 shared events · Importance 3 · Last updated May 05, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
Nektar Therapeutics: Nektar Therapeutics is the defendant in a class action lawsuit alleging misleading statements regarding its REZOLVE-AA trial, which led to a significant drop in its stock price.
Philip Kim: Philip Kim, an attorney at Rosen Law Firm, is a contact person for investors interested in joining the class action lawsuit against Nektar Therapeutics.
Apr 07, 2026 · 30 articles
NEWSDESK
Explore this relationship live
Track how Nektar Therapeutics and Philip Kim interact across events, view sentiment trends, and discover connected entities.
Open Dashboard